JP2018520352A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018520352A5 JP2018520352A5 JP2017567207A JP2017567207A JP2018520352A5 JP 2018520352 A5 JP2018520352 A5 JP 2018520352A5 JP 2017567207 A JP2017567207 A JP 2017567207A JP 2017567207 A JP2017567207 A JP 2017567207A JP 2018520352 A5 JP2018520352 A5 JP 2018520352A5
- Authority
- JP
- Japan
- Prior art keywords
- aryl
- alkylene
- alkyl
- pharmaceutical composition
- heterocycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021128745A JP2021185146A (ja) | 2015-06-23 | 2021-08-05 | アルギナーゼ活性を阻害するための組成物および方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562183524P | 2015-06-23 | 2015-06-23 | |
| US62/183,524 | 2015-06-23 | ||
| PCT/US2016/038983 WO2016210106A1 (en) | 2015-06-23 | 2016-06-23 | Compositions and methods for inhibiting arginase activity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021128745A Division JP2021185146A (ja) | 2015-06-23 | 2021-08-05 | アルギナーゼ活性を阻害するための組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018520352A JP2018520352A (ja) | 2018-07-26 |
| JP2018520352A5 true JP2018520352A5 (cg-RX-API-DMAC7.html) | 2019-07-25 |
Family
ID=57585664
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017567207A Ceased JP2018520352A (ja) | 2015-06-23 | 2016-06-23 | アルギナーゼ活性を阻害するための組成物および方法 |
| JP2021128745A Withdrawn JP2021185146A (ja) | 2015-06-23 | 2021-08-05 | アルギナーゼ活性を阻害するための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021128745A Withdrawn JP2021185146A (ja) | 2015-06-23 | 2021-08-05 | アルギナーゼ活性を阻害するための組成物および方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US10143699B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3313410A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2018520352A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20180021117A (cg-RX-API-DMAC7.html) |
| CN (1) | CN107921051A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2016281620B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2990192A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA201890113A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL256352A (cg-RX-API-DMAC7.html) |
| MA (1) | MA42269A (cg-RX-API-DMAC7.html) |
| MX (1) | MX385315B (cg-RX-API-DMAC7.html) |
| MY (1) | MY192605A (cg-RX-API-DMAC7.html) |
| PH (1) | PH12017502391A1 (cg-RX-API-DMAC7.html) |
| SG (1) | SG10202110144TA (cg-RX-API-DMAC7.html) |
| UA (1) | UA123700C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016210106A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201800328B (cg-RX-API-DMAC7.html) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2586219C2 (ru) | 2010-04-22 | 2016-06-10 | Марс, Инкорпорейтед | Ингибиторы аргиназы и их терапевтические применения |
| AU2011320732B2 (en) | 2010-10-26 | 2018-07-05 | Mars Incorporated | Boronates as arginase inhibitors |
| KR20180021117A (ko) | 2015-06-23 | 2018-02-28 | 칼리테라 바이오사이언시즈, 인코포레이티드 | 아르기나제 활성 억제를 위한 조성물 및 방법 |
| MA43131B1 (fr) * | 2015-10-30 | 2020-07-29 | Calithera Biosciences Inc | Compositions et procédés d'inhibition de l'activité de l'arginase |
| PL417066A1 (pl) | 2016-05-04 | 2017-11-06 | Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością | Inhibitory arginazy oraz ich zastosowania terapeutyczne |
| MA46793A (fr) | 2016-11-08 | 2019-09-18 | Calithera Biosciences Inc | Polythérapies faisant appel à un inhibiteur d'arginase |
| SG10201911243WA (en) | 2016-12-22 | 2020-02-27 | Calithera Biosciences Inc | Compositions and methods for inhibiting arginase activity |
| CN108794517B (zh) * | 2017-04-27 | 2021-03-30 | 南京谷睿生物科技有限公司 | 一种精氨酸酶抑制剂及其制备方法与用途 |
| EA201992695A1 (ru) * | 2017-05-12 | 2020-05-15 | Калитера Байосайнсиз, Инк. | Способ получения (3r,4s)-3-ацетамидо-4-аллил-n-(трет-бутил)пирролидин-3-карбоксамида |
| WO2019000163A1 (zh) * | 2017-06-26 | 2019-01-03 | 余祖江 | 精氨酸在制备抗肿瘤药物中的用途 |
| WO2019120296A1 (en) * | 2017-12-22 | 2019-06-27 | Guangdong Newopp Biopharmaceuticals Co., Ltd. | Heterocyclic compounds as arginase inhibitors |
| DK3752251T3 (da) | 2018-02-17 | 2025-12-15 | Astrazeneca Ab | Arginasehæmmere og fremgangsmåder til anvendelse deraf |
| SG11202008113RA (en) * | 2018-03-05 | 2020-09-29 | Arcus Biosciences Inc | Arginase inhibitors |
| US10851099B2 (en) | 2018-03-29 | 2020-12-01 | Oncoarendi Therapeutics S.A. | Dipeptide piperidine derivatives |
| CN111770756B (zh) * | 2018-04-27 | 2023-03-31 | 四川科伦博泰生物医药股份有限公司 | 非天然氨基酸类衍生物、包含其的药物组合物及其制备方法和用途 |
| RS65608B1 (sr) * | 2018-08-22 | 2024-07-31 | Astrazeneca Ab | Inhibitori arginaze i postupci za njihovo korišćenje |
| TWI828800B (zh) * | 2018-11-16 | 2024-01-11 | 美商阿克思生物科學有限公司 | Arg1及/或arg2之抑制劑 |
| WO2020104626A1 (en) * | 2018-11-21 | 2020-05-28 | Black Belt Tx Ltd | Inhibitors of arginase |
| WO2020160707A1 (en) * | 2019-02-06 | 2020-08-13 | Guangdong Newopp Biopharmaceuticals Co., Ltd. | Alkylboronic acids as arginase inhibitors |
| PT3921033T (pt) * | 2019-02-08 | 2023-10-11 | Astrazeneca Ab | Inibidores de arginase e métodos de utilização dos mesmos |
| US10967020B2 (en) * | 2019-04-05 | 2021-04-06 | King Saud University | Method of synthesizing custard apple peel nanoparticles |
| CN112110944B (zh) * | 2019-06-21 | 2022-02-11 | 南京谷睿生物科技有限公司 | 一种化合物及其制备方法和应用 |
| MX2022000904A (es) * | 2019-07-23 | 2022-05-02 | Astrazeneca Ab | Inhibidores de arginasa y métodos de uso de estos. |
| CN110734456A (zh) * | 2019-11-06 | 2020-01-31 | 南京谷睿生物科技有限公司 | 一种化合物及其制备方法和医药上的应用 |
| TW202228720A (zh) | 2020-12-22 | 2022-08-01 | 波蘭商昂科艾倫迪治療法股份公司 | 精胺酸酶抑制劑及其使用方法 |
| US20250099408A1 (en) | 2022-01-21 | 2025-03-27 | Sammy Oyoo OPIYO | Improved suramin methods and compositions |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4172896A (en) | 1978-06-05 | 1979-10-30 | Dainippon Pharmaceutical Co., Ltd. | Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same |
| GB9217295D0 (en) | 1992-08-14 | 1992-09-30 | Wellcome Found | Controlled released tablets |
| US5541231A (en) | 1993-07-30 | 1996-07-30 | Glaxo Wellcome Inc. | Stabilized Pharmaceutical |
| US5358970A (en) | 1993-08-12 | 1994-10-25 | Burroughs Wellcome Co. | Pharmaceutical composition containing bupropion hydrochloride and a stabilizer |
| GB9315856D0 (en) | 1993-07-30 | 1993-09-15 | Wellcome Found | Stabilized pharmaceutical |
| US6403609B1 (en) | 1997-07-29 | 2002-06-11 | Alcon Manufacturing, Ltd. | Ophthalmic compositions containing galactomannan polymers and borate |
| AU9797998A (en) | 1997-10-10 | 1999-05-03 | Trustees Of The University Of Pennsylvania, The | Compositions and methods for inhibiting arginase activity |
| WO1999038504A1 (en) | 1998-01-29 | 1999-08-05 | Sepracor Inc. | Pharmaceutical uses of optically pure (-)-bupropion |
| US20040063666A1 (en) | 1998-10-09 | 2004-04-01 | David Christianson | Compositions for inhibiting arginase activity |
| US8889112B2 (en) | 1999-09-16 | 2014-11-18 | Ocularis Pharma, Llc | Ophthalmic formulations including selective alpha 1 antagonists |
| EP1299398A1 (en) * | 2000-07-06 | 2003-04-09 | Fal Diagnostics | Methods and kits for the detection of arginine compounds |
| CA2431080A1 (en) | 2003-06-02 | 2004-12-02 | Catherine Adele O'brien | Enhancement of anticancer immunity through inhibition of arginase |
| US6933289B2 (en) | 2003-07-01 | 2005-08-23 | Allergan, Inc. | Inhibition of irritating side effects associated with use of a topical ophthalmic medication |
| ES2593113T3 (es) | 2003-08-07 | 2016-12-05 | Allergan, Inc. | Composiciones para el suministro de agentes terapéuticos en los ojos y métodos para obtener y usar los mismos |
| US20050059744A1 (en) | 2003-09-12 | 2005-03-17 | Allergan, Inc. | Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| EP1915143A4 (en) | 2005-07-01 | 2009-11-11 | Univ Johns Hopkins | ARGINASE II: TARGET TREATMENT FOR THE AGING HEART AND HEART FAILURE |
| CN101755130B (zh) | 2007-07-12 | 2012-10-17 | 山洋电气株式会社 | 双重反转式轴流鼓风机 |
| DK2389352T3 (da) * | 2009-01-26 | 2019-07-29 | Univ Pennsylvania | Arginaseinhibitorer og anvendelsesfremgangsmåder |
| RU2586219C2 (ru) * | 2010-04-22 | 2016-06-10 | Марс, Инкорпорейтед | Ингибиторы аргиназы и их терапевтические применения |
| AU2011320732B2 (en) | 2010-10-26 | 2018-07-05 | Mars Incorporated | Boronates as arginase inhibitors |
| CN104857005B (zh) | 2010-12-31 | 2019-04-26 | 阿斯利康公司 | 精氨酸酶抑制剂及其使用方法 |
| AU2012326109A1 (en) | 2011-10-19 | 2014-05-29 | Mars, Incorporated | Inhibitors of arginase and their therapeutic applications |
| CN104394869A (zh) | 2011-10-20 | 2015-03-04 | 葛兰素史密斯克莱有限责任公司 | 用作沉默调节蛋白调节剂的取代的双环氮杂杂环化合物和类似物 |
| EP2852598B3 (en) * | 2012-04-18 | 2016-10-19 | Mars, Incorporated | Ring constrained analogs as arginase inhibitors |
| EP3060251A4 (en) | 2013-10-25 | 2017-12-06 | Pharmacyclics LLC | Treatment using bruton's tyrosine kinase inhibitors and immunotherapy |
| CN105879030A (zh) | 2014-09-30 | 2016-08-24 | 复旦大学 | 治疗肿瘤的增效药物复合物及其制备方法 |
| EP3270907A1 (en) | 2015-03-20 | 2018-01-24 | Sammy Oyoo OPIYO | Use of suramin and arginase inhibitors in malignant neoplasia |
| KR20180021117A (ko) | 2015-06-23 | 2018-02-28 | 칼리테라 바이오사이언시즈, 인코포레이티드 | 아르기나제 활성 억제를 위한 조성물 및 방법 |
-
2016
- 2016-06-23 KR KR1020187002201A patent/KR20180021117A/ko not_active Ceased
- 2016-06-23 EA EA201890113A patent/EA201890113A1/ru unknown
- 2016-06-23 JP JP2017567207A patent/JP2018520352A/ja not_active Ceased
- 2016-06-23 MX MX2017016868A patent/MX385315B/es unknown
- 2016-06-23 EP EP16815284.1A patent/EP3313410A4/en not_active Withdrawn
- 2016-06-23 CA CA2990192A patent/CA2990192A1/en not_active Abandoned
- 2016-06-23 CN CN201680048714.7A patent/CN107921051A/zh active Pending
- 2016-06-23 WO PCT/US2016/038983 patent/WO2016210106A1/en not_active Ceased
- 2016-06-23 UA UAA201800583A patent/UA123700C2/uk unknown
- 2016-06-23 SG SG10202110144T patent/SG10202110144TA/en unknown
- 2016-06-23 MY MYPI2017704875A patent/MY192605A/en unknown
- 2016-06-23 US US15/190,653 patent/US10143699B2/en active Active
- 2016-06-23 AU AU2016281620A patent/AU2016281620B2/en not_active Ceased
- 2016-06-23 MA MA042269A patent/MA42269A/fr unknown
-
2017
- 2017-12-17 IL IL256352A patent/IL256352A/en unknown
- 2017-12-21 PH PH12017502391A patent/PH12017502391A1/en unknown
-
2018
- 2018-01-17 ZA ZA2018/00328A patent/ZA201800328B/en unknown
- 2018-08-27 US US16/113,816 patent/US10398714B2/en not_active Expired - Fee Related
-
2019
- 2019-07-29 US US16/525,403 patent/US10905701B2/en not_active Expired - Fee Related
-
2020
- 2020-11-19 US US16/953,125 patent/US20210077510A1/en not_active Abandoned
-
2021
- 2021-08-05 JP JP2021128745A patent/JP2021185146A/ja not_active Withdrawn